Barchart on MSN
Amgen Stock: Analyst Estimates & Ratings
Amgen stock has been underperforming the broader market over the past year, and analysts are adopting a cautiously bullish ...
Over the past year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a significant stake in the company which may ...
In the current session, Amgen Inc. (NASDAQ: AMGN) is trading at $291.80, after a 0.07% drop. Over the past month, the stock fell by 2.04%, and in the past year, by 7.92%. With performance like this, ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Zacks Investment Research on MSN
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Zacks Investment Research on MSN
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Denny’s board unanimously approved the deal, which values Denny’s at $620 million including debt. Denny’s will be purchased ...
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth ...
iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to ...
suggests a Moderate Buy analyst consensus rating for Amgen with a $323.38 average price target, implying a 10.8% upside from current levels. In a report issued on October 24, Oppenheimer also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results